病理T1期膀胱癌整块切除后是否需要重复经尿道电切?
该多机构回顾性研究分析106例pT1高级别膀胱癌患者,比较整块切除后行与未行重复经尿道电切(reTUR)者的预后。两组2年无复发生存率和3年无进展生存率无显著差异,reTUR未发现pT2升级;水平切缘阴性者原部位无复发,垂直切缘阳性为无进展生存更差的独立预后因素。作者认为切缘阴性者可省略reTUR,切缘阳性者仍应行reTUR。
要点
- 整块切除后行与未行reTUR者2年无复发生存率、3年无进展生存率无显著差异。
- reTUR未发现pT2升级;水平切缘阳性者reTUR检出6例pTa/is残留。
- 垂直切缘阳性为无进展生存更差的独立预后因素;切缘阴性者可省略reTUR。
核心结论
- pT1膀胱癌整块切除后行reTUR似乎未改善复发或进展。
- 切缘状态影响预后和reTUR结果;切缘阴性者可省略reTUR,水平或垂直切缘阳性者reTUR仍为标准直至被证明有其他选择。
研究设计与样本
- 多机构回顾性分析2013年4月至2021年2月间接受整块切除的106例pT1高级别膀胱癌患者记录。
- 所有标本由泌尿生殖病理学家审阅;主要结局为行与未行reTUR患者的无复发生存率和无进展生存率。
主要发现
- 106例中50例行reTUR;行与未行reTUR者2年无复发生存率55.1% vs 59.9%(P=0.6),3年无进展生存率80.6% vs 82.6%(P=0.6)。
- reTUR未发现pT2升级;51例水平切缘阴性者原部位无复发。
- Cox比例风险分析显示垂直切缘阳性为无进展生存更差的独立预后因素。
- reTUR中,水平切缘阳性者检出6例pTa/is残留;1例垂直切缘阳性或其他不良病理特征者检出3例pT1残留。
关键数值与推荐
- 行reTUR者2年无复发生存率55.1% vs 未行reTUR者59.9%(P=0.6)。
- 行reTUR者3年无进展生存率80.6% vs 未行reTUR者82.6%(P=0.6)。
- 水平切缘阳性者reTUR检出6例pTa/is残留;垂直切缘阳性或其他不良病理特征者reTUR检出3例pT1残留。
临床怎么用
- 作者认为pT1膀胱癌整块切除后切缘阴性者可省略reTUR。
- 作者认为水平或垂直切缘阳性者reTUR仍为标准直至被证明有其他选择。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: To assess the clinical significance of repeat transurethral resection (reTUR) and surgical margin status after en bloc resection of bladder tumour (ERBT) for pathological T1 (pT1) bladder cancer. PATIENTS AND METHODS: We retrospectively analysed the record of 106 patients with pT1 high-grade bladder cancer who underwent ERBT between April 2013 and February 2021 at multiple institutions. All specimens were reviewed by a genitourinary pathologist. The primary outcome measures were recurrence-free survival (RFS) and progression-free survival (PFS) between patients with and those without reTUR. We also analysed the predictive value of surgical margin on the likelihood of residual tumour on reTUR. RESULTS: A reTUR was performed in 50 of the 106 patients. The 2-year RFS and 3-year PFS were comparable between patients who underwent reTUR and those who did not (55.1% vs 59.9%, P = 0.6, 80.6% vs 82.6%, P = 0.6, respectively). No patient was upstaged to pT2 on reTUR. Regarding the surgical margin status, there were no recurrences at the original site in 51 patients with negative horizontal margins. Cox proportional hazard analysis revealed that a positive vertical margin was an independent prognostic factor of worse PFS. On reTUR, six pTa/is residues were detected in patients with a positive horizontal margin, and three pT1 residues were detected in one patient with a positive vertical margin or other adverse pathological features. CONCLUSIONS: A reTUR after ERBT for pT1 bladder cancer appears not to improve either recurrence or progression. Surgical margin status affects prognosis and reTUR outcomes. A reTUR can be omitted after ERBT in patients with pT1 bladder cancer and negative margins; for those with positive horizontal or vertical margins, reTUR should remain the standard until proven otherwise.
引用
- Yanagisawa T, Sato S, Hayashida Y, et al. Do we need repeat transurethral resection after en bloc resection for pathological T1 bladder cancer? BJU Int. 2022. PMID: 35488409. doi:10.1111/bju.15760
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。